Ambroxol as a novel disease-modifying treatment for Parkinson’s disease dementia: protocol for a single-centre, randomized, double-blind, placebo-controlled trial
C. R. A. Silveira
◽
J. MacKinley
◽
K. Coleman
◽
Z. Li
◽
E. Finger
◽
...
2006 ◽
Vol 14
(7S_Part_5)
◽
pp. P296-P296
Stephen H. Pasternak
◽
Carolina Silveira
◽
Zhonghan Li
◽
Robert Bartha
◽
Michael Borrie
◽
...
John O'Brien
◽
John-Paul Taylor
2010 ◽
Vol 9
(10)
◽
pp. 969-977
◽
Murat Emre
◽
Magda Tsolaki
◽
Ubaldo Bonuccelli
◽
Alain Destée
◽
Eduardo Tolosa
◽
...
Irene Litvan
◽
Rita Simoes
Si-chun Gu
◽
Jie Zhou
◽
Qing Ye
◽
Can-xing Yuan
2007 ◽
Vol 22
(2)
◽
pp. 179-186
◽
Christopher G. Goetz
◽
Philippe Damier
◽
Christine Hicking
◽
Eugene Laska
◽
Thomas Müller
◽
...
2011 ◽
Vol 27
(1)
◽
pp. 106-112
◽
Fabrizio Stocchi
◽
Rupam Borgohain
◽
Marco Onofrj
◽
Anthony H.V. Schapira
◽
Mohit Bhatt
◽
...
2017 ◽
Vol 390
(10103)
◽
pp. 1664-1675
◽
Dilan Athauda
◽
Kate Maclagan
◽
Simon S Skene
◽
Martha Bajwa-Joseph
◽
Dawn Letchford
◽
...
2010 ◽
Vol 9
(6)
◽
pp. 573-580
◽
Paolo Barone
◽
Werner Poewe
◽
Stefan Albrecht
◽
Catherine Debieuvre
◽
Dan Massey
◽
...
Close
Export Citation Format
Close
Share Document
Close